TP53INP1 and type 2 diabetes mellitus: Thus, despite the lack of alterations in the measured myogenic markers, we propose that the downregulation of TP53INP1 in muscle precursor cells from people with T2DM might affect the early state of myogenesis leading to an imbalance between apoptosis and cell cycle exit, which may disturb proper differentiation.